drugset / Trial / NCT00668109

Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia

NCT00668109

Phase 3 Completed 614 enrolled Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

Assessment of efficacy of vardenafil in subjects with erectile dysfunction and diabetes, hypertension or hyperlipidemia

Timeline

Start
2003-12
Primary completion
2004-06
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 10 mg
Subject Vardenafil Small molecule 10 mg

Indications